RESTRUCTURING

12 Months Ended

Dec. 31, 2023

Restructuring and Related Activities [Abstract]

During the quarters ended March 31, 2023 and September 30, 2022, the Company completed evaluations to sufficient levels of detail to commit to restructuring plans that resulted in reductions to its workforce of approximately 11% and 6%, respectively. One-time termination benefits provided as part of the restructuring plans include severance, continuation of health insurance coverage and other benefits for a specified period of time, which resulted in $4.9 million and $4.2 million of restructuring costs for the years ended December 31, 2023 and 2022, respectively.

Costs related to these restructuring plans have been recognized in the accompanying consolidated statement of operations as follows:


	Year Ended December 31,
	2023		2022
	(In thousands)
Restructuring costs:
Cost of Revenue	$	298	$	—
Research and development expense	2,813		2,282
Sales and marketing expense	1,078		1,133
General and administrative expense	699		768
Total	$	4,888	$	4,183

As of December 31, 2023, all payments under the restructuring plans have been made.